TriCor Indirect Purchasers' Attys Seek $22M In Fees
By Ben James ( September 9, 2009, 4:06 PM EDT) -- Attorneys for indirect purchaser plaintiffs in a class action accusing Abbott Laboratories and Fournier Industrie et Sante of blocking generic competition for cholesterol drug TriCor have asked a federal judge to award them almost $22 million in fees — one-third of a $65.7 million class settlement fund....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.